Aegerion Pharmaceuticals, Inc. - FORM 10-Q - EX-23 - CONSENT OF L.E.K. CONSULTING LLC - December 6, 2010

Attached files

file filename
10-Q - FORM 10-Q - Aegerion Pharmaceuticals, Inc.d10q.htm
EX-32.2 - SECTION 906 CFO CERTIFICATION - Aegerion Pharmaceuticals, Inc.dex322.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - Aegerion Pharmaceuticals, Inc.dex321.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - Aegerion Pharmaceuticals, Inc.dex311.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - Aegerion Pharmaceuticals, Inc.dex312.htm

Exhibit 23

Consent of L.E.K. Consulting LLC

L.E.K. Consulting LLC (“L.E.K.”) hereby consents to the use of L.E.K.’s name and the statements attributed to L.E.K. in the periodic reports of Aegerion Pharmaceuticals, Inc. (the “Company”) filed with the Securities and Exchange Commission, and any amendments thereto (collectively, the “Periodic Reports”), provided that the statements attributed to L.E.K and the use of L.E.K.’s name in the Periodic Reports are in the same form as the statements attributed to L.E.K. and the use of L.E.K.’s name in the Company’s Registration Statement on Form S-1 (Registration No: 333-1687214) dated September 17, 2010.

 

L.E.K. CONSULTING LLC

/s/ Shuba Satyaprasad

Shuba Satyaprasad, Esq.
General Counsel

December 1, 2010

Boston, MA

 

2

Aegerion Pharmaceuticals, Inc. Reports